ArticleJournal of thoracic disease2025
Impact of the corona virus disease 2019 pandemic on the prevalence of common respiratory pathogens in hospitalized young patients with non-severe community-acquired pneumonia.
Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
- Erratum issued
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Community-acquired pneumonia (CAP) remains a significant global health concern, yet the characteristics of non-severe CAP in young adults, particularly following the corona virus disease 2019 (COVID-19) pandemic, are not well elucidated. This study aimed to investigate the impact of COVID-19 infection on the epidemiological trends of common respiratory pathogens in young patients with non-severe CAP and to provide a theoretical basis for treatment protocols. Methods: A retrospective analysis was conducted on data from all young CAP patients hospitalized at The Third Affiliated Hospital of Guangzhou Medical University from January 2018 to December 2023. The respiratory pathogen profiles of young CAP inpatients were compared across three periods: pre-pandemic (January 2018 to December 2019), during the pandemic (January 2020 to December 2022), and post-pandemic (January 2023 to December 2023). Descriptive statistical analysis was used to evaluate the epidemiological characteristics, infection seasonality, and patterns of CAP patients. The Chi-squared or Fisher's exact test was used to compare the differences in pathogen positivity rates and co-infection rates among different stages. Results: There were no significant differences in age, white blood cell count, neutrophil count, lymphocyte count, and C-reactive protein (CRP) among the three groups of young non-severe CAP inpatients. The proportion of males showed statistical significance among the three groups: pre-pandemic (12.5%), during the pandemic (28%), and post-pandemic (23.23%). The proportion of young CAP inpatients to total CAP inpatients also differed significantly: pre-pandemic (17.75%), during the pandemic (11.93%), and post-pandemic (23.77%). Changes in pathogen profiles were as follows: bacterial infection rates-pre-pandemic (6.25%), during the pandemic (10%), post-pandemic (21.38%); viral infection rates-pre-pandemic (10.94%), during the pandemic (19%), post-pandemic (23.90%); Mycoplasma infection rates-pre-pandemic (56.25%), during the pandemic (46%), post-pandemic (35.22%); co-infection rates-pre-pandemic (7.81%), during the pandemic (13%), post-pandemic (20.75%). These differences were statistically significant among the three groups. The rate of bacterial-bacterial co-infections significantly increased: pre-pandemic (20%), during the pandemic (53.85%), and post-pandemic (72.72%), with significant differences among the three groups. The top five pathogens in each stage were pre-pandemic- Conclusions: Following COVID-19 infection, the incidence of CAP in young people increased, with changes in pathogen profiles. There was an increase in bacterial and viral infections, a significant rise in co-infections, predominantly bacterial-bacterial infections, and more atypical pathogen infections were observed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.